Mass. Federal Judge Recommends Termination of Fresenius Dialysis Products MDL
September 25, 2023
BOSTON — After dismissing 13 actions earlier this month, the judge overseeing the federal MDL docket for claims relating to Fresenius’ GranuFlo and NaturaLyte dialysis products has closed the master docket and recommended that the Judicial Panel on Multidistrict Litigation close the case.
Judge Nathaniel M. Gorton of the U.S. District Court for the District of Massachusetts issued the order on Sept. 19.
GranuFlo and NaturaLyte, manufactured by Fresenius Medical Care North America Inc., are dry acid concentrates used during dialysis to draw fluids and toxins out of the bloodstream while replenishing the blood with electrolytes and other chemicals.